Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Operating Expenses | 4,467 | 4,466 | 4,626 | 5,385 | -4,157 |
| Operating Income | -4,467 | -4,466 | -4,626 | -5,385 | 4,157 |
| Interest Expense | N/A | 0 | 134 | N/A | N/A |
| Other Income | 4,467 | 4,466 | 4,760 | 5,385 | -4,157 |
| Net Income Continuous | -4,459 | -4,447 | -4,568 | -5,507 | -4,084 |
| Net Income | $-4,459 | $-4,447 | $-4,568 | $-5,507 | $-4,084 |
| EPS Basic Total Ops | -9.00 | -8.60 | -12.33 | -24.24 | -23.16 |
| EPS Basic Continuous Ops | -9.00 | -8.60 | -12.33 | -24.24 | -23.16 |
| EPS Diluted Total Ops | -9.00 | -8.60 | -12.33 | -24.24 | -23.16 |
| EPS Diluted Continuous Ops | -9.00 | -8.60 | -12.33 | -24.24 | -23.16 |
| EBITDA(a) | $-4,209 | $-4,209 | $-4,399 | $-5,099 | $4,403 |